[1] | Bruni L, Barrionuevo-Rosas L, Albero G, Serrano B, Mena M, Gómez D, et al. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World. Summary Report 27 July 2017. |
[2] | Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136(5): E359-86. doi: 10.1002/ijc.29210. |
[3] | Canfell K, Sitas F, Beral V. Cervical Cancer in Australia and the United Kingdom: Comparison of Screening Policy and Uptake and Cancer Incidence and Mortality. Med J Aust 2006; 185(9): 482-486. |
[4] | Anorlu RI. Cervical cancer: the sub-Saharan African perspective, Reproductive Health Matters 2008; 16(32): 41-49, DOI: 10.1016/S0968-8080(08)32415-X. |
[5] | Xie X, Gou WL. Obstetrics and Gynecology. 8 version, People’s Health Publishing House, Beijing, China, 2013. |
[6] | Ghebre RG, Grover S, Xu MJ, Chuang LT, Simonds H. Cervical cancer control in HIV-infected women: Past, present, and future. Gynecologic Oncology Reports 2017; 21: 101–108. |
[7] | Agorastos T, Miliaras D, Lambropoulos A, Chrisafi S, Kotsis A, Manthos A, et al. "Detection and typing of human papillomavirus DNA in uterine cervices with coexistent grade I and grade III intraepithelial neoplasia: biologic progression or independent lesions?". Eur J Obstet Gynecol Reprod Biol 2005; 121(1): 99–103. doi:10.1016/j.ejogrb.2004.11.024. PMID 15949888. |
[8] | Oguntayo OA. Cervical Intraepithelial Neoplasia (CIN) (Squamous Dysplasia), Intraepithelial Neoplasia, Dr. Supriya Srivastava (Ed.), ISBN: 978-953-307-987-5, InTech 2012. https://0x9.me/OcqQA. |
[9] | Evans DM, Hudson EA, Brown CL, Boddington MM, Hughes HE, Mackenzie EF, et al. Terminology in gynecological cytopathology: report of the Working Party of the British Society for Clinical Cytology. J Clin Pathol 1986; 39: 933-44. |
[10] | Solomon D, Davey D, Kurman R, Moriarty A, O’Connor D, Prey M, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002; 287: 2114-9. |
[11] | Richart RM. Natural history of cervical intraepithelial neoplasia. Clin Obstet Gynecol 1967; 10: 748-84. |
[12] | Franco EL, Duarte-Franco E, Ferenczy A. Prospects for controlling cervical cancer at the turn of the century. Salud Publica Mex 2004; 45 (Suppl 3):367-75. |
[13] | Arbyn M, Castellsagué X, de Sanjosé S, Bruni L, Saraiya M, Bray F, Ferlay J. Worldwide burden of cervical cancer in 2008. Ann Oncol 2011; 22(12): 2675–86. |
[14] | Ahmed SA, Ayuba HU, Maiangwa A, Vakkai VI, Dashe DR, Joel R. et al. Prevalence of squamous intraepithelial lesions of the cervix in Jalingo, Nigeria. African Journal of Cellular Pathology 2013; 1(1): 19-22. |
[15] | Obaseki DE, Nwafor CC. Cervical Cancer Screening In Benin City, South-South Nigeria. IOSR-JDMS 2013; 5(1): 16-19. |
[16] | Mosuro OA, Ajayi I, Odukogbe ATA, Adeniji AO, Oluwasola O, Ladipo MM, et al. Prevalence of cervical dysplasia and associated risk factors among women presenting at a primary care clinic in Nigeria. J Basic Clin Reprod Sci 2015; 4: 70-9. |
[17] | Abdul MA, Shittu SO, Randawa JA, Shehu MS. The cervical smear pattern in patients with chronic pelvic inflammatory disease. Niger J Clin Pract 2009; 12: 289‑93. |
[18] | Fadahunsi OO, Omoniyi-Esan GO, Banjo AA, Esimai OA, Osiagwu D. Prevalence of high risk oncogenic human papillomavirus types in cervical smears of women attending well woman clinic in Ile Ife, Nigeria. Obstet Gynecol 2013; 3:185. doi:10.4172/2161-0932.1000185. |
[19] | Njagi SK, Mugo NR, Reid AJ, Satyanarayana S, Tayler-Smith K, Kizito W, Prevalence and incidence of cervical intra-epithelial neoplasia among female sex workers in Korogocho, Kenya. Public Health Action 2013; 3(4): 271-275. doi: 10.5588/pha.13.0057. |
[20] | Ojiyi E, Okeudo C, Dike E, Anolue F, Onyeka U, Audu B, Ngadda H. The prevalence and predictors of human papillomavirus infection of the cervix at a university teaching hospital in northern Nigeria. Internet Journal of Gynecology and Obstetrics 2012; 16(2). http://ispub.com/IJGO/16/2/14219. |
[21] | Kovachev SM, Slavov VD. Causative relations between human papillomavirus infection and cervical intraepithelial neoplasia, Biotechnology & Biotechnological Equipment 2016; (30)3, 558-561, DOI: 10.1080/13102818.2016.1159922. |
[22] | Chama CM, Nggada H, Gaushau W. Cervical dysplasia in HIV infected women in Maiduguri, Nigeria. J Obstet Gynecol 2005; 25(3): 286–8. |
[23] | Agaba PA, Thacher TD, Ekwempu CC, Idoko JA. Cervical dysplasia in Nigerian women infected with HIV. Int J Gynecol Obstet 2009 Nov; 107(2): 99-102. doi: 10.1016/j.ijgo. |
[24] | Muhammad Z, Usman IH, Datti ZA, Avidime AR, Danjuma SA, Taoheed AA, Suleiman AA. Incidence and risk factors of cervical dysplasia among human immune deficiency virus positive and human immune deficiency virus negative women at Aminu Kano Teaching Hospital. Sahel Med J 2017; 20: 160-7. |
[25] | UNAIDS-3. 4 million Nigerians contracted HIV/AIDS in 2014. Available at http://www.informationng.com/2015/09/3-4m-nigerians-contracte-hivaids-in-2014-u. |
[26] | Atashili J, Adimora AA, Ndumbe PM, Ikomey GM, Rinas AC, Myers E, et al. High prevalence of cervical squamous intraepithelial lesions in women on antiretroviral therapy in Cameroon: is targeted screening feasible? Cancer Epidemiology 2012; 36(3): 263-269. doi:10.1016/j.canep. |
[27] | Moodley J, Constant D, Hoffman M, Salimo A, Allan B, Rybicki E. Human papillomavirus prevalence, viral load and pre-cancerous lesions of The cervix in women initiating highly active antiretroviral therapy in South Africa: a cross-sectional study. BMC Cancer 2009; 9(1): 275. doi: 10.1186/1471-2407-9-275. |
[28] | Parham GP, Sahasrabuddhe VV, Mwanahamuntu MH, Shepherd BE, Hicks ML, Stringer EM, et al. Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia. Gynecol Oncol 2006; 103(3): 1017-1022. |
[29] | Crosbie EJ, Einstein MH, Franceschi S, Kitchener HC. Human papillomavirus and cervical cancer. Lancet 2013; 382(9895): 889–899. |
[30] | Hawes SE, Kiviat NB. Are genital infections and inflammation cofactors in the pathogenesis of invasive cervical cancer?. Journal of National Cancer Institute 94: 2002; 1592–1593. |
[31] | Bakari F, Abdul MA, Ahmed SA. The Prevalence and Course of Preinvasive Cervical Lesions during Pregnancy in a Northern Nigerian Teaching Hospital Ann Afr Med 2017; 16(2): 74–80. doi: 10.4103/aam.aam_35_16. |
[32] | Sodhani P, Gupta S, Singh V, Sehgal A, Mitra AB. “Eliminating the diagnosis atypical squamous cells of undetermined significance: impact on the accuracy of the Papanicolaou test,” Acta Cytologica 2004; (48)6: 783–787. |
[33] | Barcelos AC, Michelin MA, Adad SJ, Murta EF. Atypical Squamous Cells of Undetermined Significance: Bethesda Classification and Association with Human Papillomavirus Infectious Diseases in Obstetrics and Gynecology Volume 2011, Article ID 904674, 9 pages doi:10.1155/2011/904674. |
[34] | Melnikoew J, Nuovo J, Willan AR. Natural history of cervical squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol. 1998; 92: 727-35. |
[35] | Poomtavorn Y, Suwannarurk K, Thaweekul Y, Maieang K. Risk factors for high-grade cervical intraepithelial neoplasia in patients with atypical squamous cells of undetermined significance (ASCUS) Papanicolaou smears. Asian Pac J Cancer Prev. 2011; 12: 235-8. |
[36] | Wiliams ML, Rimi DL, Pedigo MA. Atypical squamous cells of undetermined significance: correlative histologic and follow up studies from an academic medical center. Diagn Cytopathol. 1997; 161: 1-7. |
[37] | Barcelos A, Adad S, Michelim M, Murta E. Atypical squamous cells of undetermined significance: analysis of microbiology, cytological criteria and clinical conduct. Tumori. 2006: 213-8. |
[38] | Avidime S, Ahmed SA, Oguntayo A, Abu TO, Ndako JA. The pattern of cervical dysplasia among women of reproductive age in Zaria, Northern Nigeria. J Med Trop 2014; 16:52-5. |
[39] | Utoo BT, Utoo PM, Ngwan SD, Anzaku SA, Daniel MA. Cervical intraepithelial neoplasia: Prevalence, risk factors, and utilization of screening services among an urban population in Nigeria. Trop J Obstet Gynaecol 2016; 33: 279-83. |
[40] | Wang Z, Wang J, Fan J, Zhao W, Yang X, Wu L, et al. Risk factors for cervical intraepithelial neoplasia and cervical cancer in Chinese women: a large study in Jiexiu, Shanxi Province, China. Journal of Cancer 2017; 8(6): 924-932. doi: 10.7150/jca.17416. |
[41] | Magaji SJ, Aminu M, Inabo HI, Oguntayo AO, Ahmed SA, Yaro JD, et al. Prevalence of squamous intraepithelial lesion among women in Kaduna State, Nigeria. Ann Trop Pathol [serial online] 2017; 8: 94-8. http://www.atpjournal.org/text.asp?2017/8/2/94/225918. |
[42] | Duru CB, Oluoha RU, Uwakwe KA, Diwe KC, Merenu IA, Emerole CA, et al. Pattern of PAP Smear Test Results among Nigerian Women Attending Clinics in a teaching Hospital. Int J Curr Microbiol App Sci 2015; 4(4): 986-998. |
[43] | Rong X, Wu LN, Gao JY. "Study of the natural history of cervical intraepithelial neoplasia grade I,” Progress in Obstetrics and Gynecology 2012; 21(5): 365–368. |
[44] | Wang HH, Chen L, Chen M, Wu LL, Li JP, "Significance of high-risk human papillomavirus monitoring in the follow-up of cervical intraepithelial neoplasia?” Maternal and Child Health Care of China 2012; 27(6): 820–822. |
[45] | WHO. Cervical cancer screening in developing countries. A memorandum from a WHO meeting. Report of a WHO consultation on the control of cervical cancer in developing countries. Bull World Health Organ 2002; 74:312. |
[46] | Oguntayo OA, Samaila MO. A Prevalence of Cervical Intraepithelial Neoplasia in Zaria, Annals of African Medicine 2010; (9)3:194-5. |
[47] | Kumar V, Abbas AK, Fausto N, Mitchell RN. Cervical Dysplasia: Overview, Risk Factors. Robbins Basic Pathology (8th ed.). Saunders Elsevier 2007:718–721. ISBN 978-1-4160-2973-1. |